RECRUITING

Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Cardiac rehabilitation (CR) is a secondary prevention program for patients with cardiovascular disease (CVD). It is especially valuable as CVD increasingly occurs in combination with comorbidity, frailty, and complexities of care that predispose patients to functional decline, disability, and high costs. Still, few Veterans participate in CR, in part because of the difficult logistics to attend. Promising Practice home-based CR (HBCR) was developed to increase CR participation, but many Veterans remain too limited by comorbidity and frailty for participation. A Transition to CR (T2CR) intervention is a face-to-face program that fosters vital skills, education, insights, motivation, and patient-provider relationships conducive to successful HBCR thereafter. This study compares Veterans eligible for CR who are randomized to T2CR intervention versus usual care. Differences in functional capacity, HBCR participation, and healthy days at home are compared over one year. Patients' experiences and providers' perspectives of barriers and facilitators to T2CR are also compared.

Official Title

Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty

Quick Facts

Study Start:2024-11-01
Study Completion:2027-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06244199

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Eligible candidates will consist of male and female Veterans hospitalized with:
  2. * ischemic heart disease (acute myocardial infarction or stable ischemia)
  3. * revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
  4. * valvular heart disease (surgical or percutaneous intervention for mitral regurgitation or aortic stenosis)
  5. * or heart failure (with reduced or preserved ejection fraction)
  6. * All will be recruited while initially hospitalized and must express willingness to consider cardiac rehabilitation as a treatment option, including the possibility of the intervention which could possibly extend the length of their hospitalization (for 2 days maximum).
  7. * Study candidates must also be English speaking and able to provide written informed consent
  1. * Veterans with unstable medical condition as indicated by history, physical exam, and/or laboratory findings end-stage disease likely to be fatal within 12 months
  2. * severe cognitive impairment (MiniCog score 0-2)
  3. * history of addictive or behavioral issues that confound safe administration of HBCR
  4. * hearing loss that interferes with participation in the trial
  5. * living in a long-term care living situation prior to the time of hospitalization, no plans to return to independent living after the hospitalization

Contacts and Locations

Study Contact

Daniel E Forman, MD
CONTACT
(412) 360-2917
Daniel.Forman@va.gov
Greg A Owens, BA
CONTACT
(412) 360-1792
gregory.owens@va.gov

Principal Investigator

Daniel E Forman, MD
PRINCIPAL_INVESTIGATOR
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

Study Locations (Sites)

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130-4817
United States
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, 15240
United States

Collaborators and Investigators

Sponsor: VA Office of Research and Development

  • Daniel E Forman, MD, PRINCIPAL_INVESTIGATOR, VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-01
Study Completion Date2027-08-31

Study Record Updates

Study Start Date2024-11-01
Study Completion Date2027-08-31

Terms related to this study

Keywords Provided by Researchers

  • cardiovascular diseases
  • cardiac rehabilitation
  • transition of care

Additional Relevant MeSH Terms

  • Cardiovascular Diseases
  • Cardiac Rehabilitation
  • Transition of Care